Quality of Neuropsychological Assessment: Effect of Feedback on Neuropsychological Performance and Treatment-outcome

Completed

• Conditions: underperformance; invalid performance; 10029305; 10012272; 10024136

• Registration Number: NL-OMON47362
• Lead Sponsor: Medisch Universitair Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 512

Inclusion Criteria

- patients clinically referred for, and cognitively capable of undergoing full neuropsychological assessment
- * 18 years old
- Mental competency to give informed consent
- Dutch proficiency
- A minimum of 8 years of formal schooling and no history of mental retardation

Exclusion Criteria

Severe and obvious cognitive problems (see p. 12 of the study protocol)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The percentage of patients that score better on a repeated SVT (i.e., ASTM) and<br /><br>subsequent neuropsychological testing (i.e., VLT and SCWT) after providing<br /><br>feedback on SVT failure (FB+), compared to the percentage of patients that show<br /><br>improvement on these tests that were not given this feedback (FB-). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondly, we want to investigate to what extent SVT failure and external gain<br /><br>expectations in this sample predicts treatment-outcome according to<br /><br>self-reported health status (i.e., SF-36) and medical consumption (i.e., iMCQ)<br /><br>three months after the neuropsychological assessment. </p><br>